Search results
Rebecca Dobson
Job title: Consultant Cardiologist
Author
Author(s):
Edoardo Bertero
,
Pietro Ameri
,
Christoph Maack
Added:
3 years ago
Heart failure (HF) and cancer represent two major causes of morbidity and mortality in developed countries.1,2 The prevalence of these conditions is growing as the age of the population and the burden of shared risk factors, such as diabetes and obesity, are constantly increasing. In past decades, the field of cardio-oncology has predominantly focused on prevention and treatment of cardiovascular…
View more
Author(s):
Tomaz Podlesnikar
,
Victoria Delgado
,
Jeroen J Bax
Added:
3 years ago
Heart failure (HF) is a rapidly growing public health problem with an estimated prevalence of more than 26 million people worldwide.1 In developed countries the prevalence is 1–2% peaking at ≥10% among people aged over 70 years.2 In the US, the lifetime risk of developing HF is 20% among people aged 40 years or older.3 Diagnosing the underlying cause of HF is central to the choice of appropriate…
View more
Author(s):
David Playford
Added:
3 years ago
Prof David Playford (University of Notre Dame, Fremantle, WA, AU) discusses the lessons from the National Echocardiography Database of Australia (NEDA) in relation to preserved ejection fraction and structural heart disease in 446,848 patients.
Recorded remotely from Fremantle, 2020.
Questions:
1. What is the rationale of this study?
2. What were the aims of this study?
3. What were the…
View more
Author(s):
Estefania Oliveros
,
Yevgeniy Brailovsky
,
Paul Scully
,
et al
Added:
3 years ago
This review focuses on the implications of coronavirus disease 2019 (COVID-19) in the heart failure (HF) population. First of all, we will describe the cardiovascular implications of COVID-19 and the new practices surrounding the use of telehealth to follow up and triage patients with HF. We will then discuss the current practices supported by medical societies, the role of pharmacotherapy and,…
View more
Author(s):
Jawad Haider Butt
Added:
10 months ago
ESC-HFA 23 - Dr Jawad Haider Butt (Copenhagen University Hospital, DK) outlines the findings of a patient-level meta-analysis of the DAPA-HF and DELIVER trials, which studied the safety and effectiveness of dapagliflozin on patients with both peripheral arterial disease and heart failure. These trials covered the spectrum of patients with heart failure.
The findings of this meta-analysis suggest…
View more
Author(s):
Isla Mackenzie
Added:
1 year ago
ESC Congress 22 — Prof Isla S Mackenzie (University of Dundee, UK) reveals the findings of the ALL-HEART study, which aimed to evaluate the use of xanthine oxidase inhibitor, allopurinol- a drug reducing the production of uric acid-in patients over 60 with ischemic heart disease (IHD).
5,215 patients were included in the trial, and were randomized to receive either 600mg of allopurinol in…
View more
Author(s):
Aniket S Rali
,
Angela Weingarten
,
Emily Sandhaus
,
et al
Added:
2 years ago
Author(s):
Chia Siang Kow
,
Syed Shahzad Hasan
Added:
3 years ago
Dear Editor,
We read, with great interest, the review article written by Oliveros et al. entitled ‘Coronavirus Disease 2019 and Heart Failure: A Multiparametric Approach’, which comprehensively summarises the clinical characteristics of cardiovascular complications associated with coronavirus disease 2019 (COVID-19) and the use of telehealth in patients with heart failure.1 This review should be…
View more
Author(s):
Emilia D’Elia
,
Michele Senni
Added:
3 years ago
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes coronavirus disease 2019 (COVID-19), which has reached a pandemic level worldwide.1 Bergamo was the first western town affected by the COVID-19 pandemic and has the sad record of being the city with the highest number of COVID-19 cases and deaths, not only in the Lombardy region but also throughout Italy and the world. The first…
View more